Pediatric aspects of bioterrorism

  • Kwang Sik Kim
Part of the Birkhäuser Advances in Infectious Diseases book series (BAID)


Potential microbes for bioterrorism threats include Bacillus anthrax, Yersinia pestis, Francisella tularemia, Clostridium botulinum, variola virus and hemorrhagic fever viruses such as Ebola. This review covers selective topics associated with anthrax and smallpox, such as epidemiology, pathogenesis, clinical presentation, diagnosis, prevention, and therapy, as well as approaches for clinical management of children in suspected exposure to anthrax and smallpox. Information is lacking regarding weaponized anthrax spores, including LD50, optimal management, alternatives for antibiotic-resistant strains and use of genetically modified strains to escape vaccine protection. The recent US outbreak in 2001 highlights the following features: case fatality rates of 45%, no secondary cases among household contacts of the inhalation anthrax subjects and no cases of anthrax among individuals on antibiotic prophylaxis. Regarding smallpox, discussions have concerned the identification of first response individuals and vaccination of such individuals; however, smallpox vaccine is associated with mortality and morbidity, and current issues include principles and procedures associated with vaccination.


West Nile Virus Rift Valley Fever Clostridium Botulinum Yersinia Pestis Nipah Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    American Academy of Pediatrics (2000) Chemical-biological terrorism and its impact on children: A subject review. Pediatrics 105: 662–670CrossRefGoogle Scholar
  2. 2.
    Markenson D, Reynolds S (2006) American academy of pediatric committee on pediatric emergency medicine; Task Force terrorism, the pediatrician and disaster preparedness. Pediatrics 117: e340–362PubMedCrossRefGoogle Scholar
  3. 3.
    Inglesby TV, Otoole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J (2002) Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 287: 2236–2252PubMedCrossRefGoogle Scholar
  4. 4.
    Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH (1993) Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci USA 90: 2291–2294PubMedCrossRefGoogle Scholar
  5. 5.
    Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, Yampolskaya O (1994) The Sverdlovsk anthrax outbreak of 1979. Science 266: 1202–1208PubMedCrossRefGoogle Scholar
  6. 6.
    Guarner J, Jernigan JA, Shieh WJ, Tatti K, Flannagan LM, Stephens DS, Perkins BA, Zaki SR, Inhalational Anthrax Pathology Working Group (2003) Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol 163: 701–709PubMedGoogle Scholar
  7. 7.
    Fritz DL, Jaax NK, Lawrence WB, Davis KJ, Pitt ML, Essell JW, Friedlander AM (1995) Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest 73: 691–702PubMedGoogle Scholar
  8. 8.
    Vasconcelos D, Barnewall R, Babin M, Hunt R, Estep J, Nielsen C, Carnes R, Carney J (2003) Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). Lab Invest 83: 1201–1209PubMedCrossRefGoogle Scholar
  9. 9.
    Freedman A, Afonja O, Chang MW, Mostashari F, Blaser M, Perez-Perez G, Lazarus H, Schacht R, Guttenberg J, Traister M, Borowsky W (2002) Cutaneous anthrax associated with microagniopathic hemolytic anemia and coagulopathy in a 7-month-old infant. JAMA 287: 869–874PubMedCrossRefGoogle Scholar
  10. 10.
    Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm Mt et al (1999) Smallpox as a biological weapon: medical and public health management. Working group on Civilian Biodefense. JAMA 281: 2127–2237PubMedCrossRefGoogle Scholar
  11. 11.
    American Academy of Pediatrics — Policy Statement (2002) Smallpox vaccine. Pediatrics 110: 841–845CrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2007

Authors and Affiliations

  • Kwang Sik Kim
    • 1
  1. 1.Johns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations